191 related articles for article (PubMed ID: 35406720)
21. Amphiphilic Peptides for Efficient siRNA Delivery.
Mozaffari S; Bousoik E; Amirrad F; Lamboy R; Coyle M; Hall R; Alasmari A; Mahdipoor P; Parang K; Montazeri Aliabadi H
Polymers (Basel); 2019 Apr; 11(4):. PubMed ID: 30999603
[TBL] [Abstract][Full Text] [Related]
22. Design and characterization of a new peptide vector for short interfering RNA delivery.
Chen B; Xu W; Pan R; Chen P
J Nanobiotechnology; 2015 Jun; 13():39. PubMed ID: 26054932
[TBL] [Abstract][Full Text] [Related]
23. (18)F-Labeled phosphopeptide-cell-penetrating peptide dimers with enhanced cell uptake properties in human cancer cells.
Richter S; Bouvet V; Wuest M; Bergmann R; Steinbach J; Pietzsch J; Neundorf I; Wuest F
Nucl Med Biol; 2012 Nov; 39(8):1202-12. PubMed ID: 22784382
[TBL] [Abstract][Full Text] [Related]
24. Cyclic peptide-capped gold nanoparticles for enhanced siRNA delivery.
Shirazi AN; Paquin KL; Howlett NG; Mandal D; Parang K
Molecules; 2014 Aug; 19(9):13319-31. PubMed ID: 25170952
[TBL] [Abstract][Full Text] [Related]
25. Cyclic Peptide Containing Hydrophobic and Positively Charged Residues as a Drug Delivery System for Curcumin.
Shirazi AN; El-Sayed NS; Tiwari RK; Tavakoli K; Parang K
Curr Drug Deliv; 2016; 13(3):409-17. PubMed ID: 26511089
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antiproliferative activities of doxorubicin thiol conjugates and doxorubicin-SS-cyclic peptide.
Darwish S; Sadeghiani N; Fong S; Mozaffari S; Hamidi P; Withana T; Yang S; Tiwari RK; Parang K
Eur J Med Chem; 2019 Jan; 161():594-606. PubMed ID: 30396106
[TBL] [Abstract][Full Text] [Related]
27. Impact of Peptide Sequence on Functional siRNA Delivery and Gene Knockdown with Cyclic Amphipathic Peptide Delivery Agents.
Jagrosse ML; Baliga UK; Jones CW; Russell JJ; García CI; Najar RA; Rahman A; Dean DA; Nilsson BL
Mol Pharm; 2023 Dec; 20(12):6090-6103. PubMed ID: 37963105
[TBL] [Abstract][Full Text] [Related]
28. Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs.
Nasrolahi Shirazi A; Tiwari R; Chhikara BS; Mandal D; Parang K
Mol Pharm; 2013 Feb; 10(2):488-99. PubMed ID: 23301519
[TBL] [Abstract][Full Text] [Related]
29. Design and application of hybrid cyclic-linear peptide-doxorubicin conjugates as a strategy to overcome doxorubicin resistance and toxicity.
Mozaffari S; Salehi D; Mahdipoor P; Beuttler R; Tiwari R; Aliabadi HM; Parang K
Eur J Med Chem; 2021 Dec; 226():113836. PubMed ID: 34537446
[TBL] [Abstract][Full Text] [Related]
30. An Amphipathic Structure of a Dipropylglycine-Containing Helical Peptide with Sufficient Length Enables Safe and Effective Intracellular siRNA Delivery.
Oba M; Shibuya M; Yamaberi Y; Yokoo H; Uchida S; Ueda A; Tanaka M
Chem Pharm Bull (Tokyo); 2023; 71(3):250-256. PubMed ID: 36858531
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and evaluation of tripodal peptide analogues for cellular delivery of phosphopeptides.
Ye G; Nam NH; Kumar A; Saleh A; Shenoy DB; Amiji MM; Lin X; Sun G; Parang K
J Med Chem; 2007 Jul; 50(15):3604-17. PubMed ID: 17580848
[TBL] [Abstract][Full Text] [Related]
32. Developing and Testing Methylated Nano-Structured Dipeptides that Inhibit Src Kinase Activity In Vitro for Anti-Cancer Applications.
Nahhas AF; Nahhas AF; Webster TJ
J Vis Exp; 2022 Nov; (189):. PubMed ID: 36533825
[TBL] [Abstract][Full Text] [Related]
33. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
Mo RH; Zaro JL; Shen WC
Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and evaluation of chitosan conjugated GGRGDSK peptides as a cancer cell-targeting molecular transporter.
El-Sayed NS; Shirazi AN; El-Meligy MG; El-Ziaty AK; Nagieb ZA; Parang K; Tiwari RK
Int J Biol Macromol; 2016 Jun; 87():611-22. PubMed ID: 26976071
[TBL] [Abstract][Full Text] [Related]
35. siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells.
Furukawa K; Tanaka M; Oba M
Bioorg Med Chem; 2020 Apr; 28(8):115402. PubMed ID: 32146061
[TBL] [Abstract][Full Text] [Related]
36. Fatty acid modified octa-arginine for delivery of siRNA.
Li Y; Li Y; Wang X; Lee RJ; Teng L
Int J Pharm; 2015 Nov; 495(1):527-535. PubMed ID: 26386137
[TBL] [Abstract][Full Text] [Related]
37. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
[TBL] [Abstract][Full Text] [Related]
38. Distal phenylalanine modification for enhancing cellular delivery of fluorophores, proteins and quantum dots by cell penetrating peptides.
Sayers EJ; Cleal K; Eissa NG; Watson P; Jones AT
J Control Release; 2014 Dec; 195():55-62. PubMed ID: 25108152
[TBL] [Abstract][Full Text] [Related]
39. Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate.
Govindarajan S; Sivakumar J; Garimidi P; Rangaraj N; Kumar JM; Rao NM; Gopal V
Biomaterials; 2012 Mar; 33(8):2570-82. PubMed ID: 22192536
[TBL] [Abstract][Full Text] [Related]
40. Biodegradable stearylated peptide with internal disulfide bonds for efficient delivery of siRNA in vitro and in vivo.
Tai Z; Wang X; Tian J; Gao Y; Zhang L; Yao C; Wu X; Zhang W; Zhu Q; Gao S
Biomacromolecules; 2015 Apr; 16(4):1119-30. PubMed ID: 25686200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
